Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Lax

Showing results (61-70 of 98) with videos related to

Pageof 10
Sort By:
Virchows Archiv : an International Journal of Pathology|October 31, 2002
Quality assurance for detection of estrogen and progesterone receptors by immunohistochemistry in Austrian pathology laboratoriesPeter Regitnig, Angelika Reiner, Hans-Peter Dinges, et al.
Virchows Archiv : an International Journal of Pathology|February 9, 2019
Comprehensive analysis of PD-L1 expression, HER2 amplification, ALK/EML4 fusion, and mismatch repair deficiency as putative predictive and prognostic factors in ovarian carcinomaElisa Schmoeckel, Sophie Hofmann, Daniel Fromberger, et al.
The Lancet. Oncology|July 28, 2022
Terminology for cone dimensions after local conservative treatment for cervical intraepithelial neoplasia and early invasive cervical cancer: 2022 consensus recommendations from ESGO, EFC, IFCPC, and ESPMaria Kyrgiou, Antonios Athanasiou, Marc Arbyn, et al.
Oncotarget|May 1, 2018
<i>BRCA1/2</i> and <i>TP53</i> mutation status associates with <i>PD-1</i> and <i>PD-L1</i> expression in ovarian cancerVerena Wieser, Inge Gaugg, Martina Fleischer, et al.
British Journal of Cancer|August 17, 2018
BRCA1 and BRCA2 mRNA-expression prove to be of clinical impact in ovarian cancerIrina Tsibulak, Verena Wieser, Christine Degasper, et al.
Carcinogenesis|April 3, 1998
Induction and localization of cytochrome P450 1B1 (CYP1B1) protein in the livers of TCDD-treated rats: detection using polyclonal antibodies raised to histidine-tagged fusion proteins produced and purified from bacteriaN J Walker, F G Crofts, Y Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2020
Predictive Value of Molecular Subtypes in Premenopausal Women with Hormone Receptor-positive Early Breast Cancer: Results from the ABCSG Trial 5Zsuzsanna Bago-Horvath, Margaretha Rudas, Christian F Singer, et al.
Der Pathologe|February 12, 2021
[Systemic consequences and clinical aspects of SARS-CoV-2 infection]Sigurd F Lax, Kristijan Skok, Peter M Zechner, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 8, 2008
CYP1B1 is not a major determinant of the disposition of aromatase inhibitors in epithelial cells of invasive ductal carcinomaMostafizur Rahman, Sigurd F Lax, Carrie H Sutter, et al.
Der Pathologe|February 24, 2021
[Practical aspects of COVID-19 autopsies]Peter Boor, Philip Eichhorn, Arndt Hartmann, et al.
Pageof 10

Showing results (61-70 of 98) with videos related to

Sort By:
Pageof 10
Virchows Archiv : an International Journal of Pathology|October 31, 2002
Quality assurance for detection of estrogen and progesterone receptors by immunohistochemistry in Austrian pathology laboratoriesPeter Regitnig, Angelika Reiner, Hans-Peter Dinges, et al.
Virchows Archiv : an International Journal of Pathology|February 9, 2019
Comprehensive analysis of PD-L1 expression, HER2 amplification, ALK/EML4 fusion, and mismatch repair deficiency as putative predictive and prognostic factors in ovarian carcinomaElisa Schmoeckel, Sophie Hofmann, Daniel Fromberger, et al.
The Lancet. Oncology|July 28, 2022
Terminology for cone dimensions after local conservative treatment for cervical intraepithelial neoplasia and early invasive cervical cancer: 2022 consensus recommendations from ESGO, EFC, IFCPC, and ESPMaria Kyrgiou, Antonios Athanasiou, Marc Arbyn, et al.
Oncotarget|May 1, 2018
<i>BRCA1/2</i> and <i>TP53</i> mutation status associates with <i>PD-1</i> and <i>PD-L1</i> expression in ovarian cancerVerena Wieser, Inge Gaugg, Martina Fleischer, et al.
British Journal of Cancer|August 17, 2018
BRCA1 and BRCA2 mRNA-expression prove to be of clinical impact in ovarian cancerIrina Tsibulak, Verena Wieser, Christine Degasper, et al.
Carcinogenesis|April 3, 1998
Induction and localization of cytochrome P450 1B1 (CYP1B1) protein in the livers of TCDD-treated rats: detection using polyclonal antibodies raised to histidine-tagged fusion proteins produced and purified from bacteriaN J Walker, F G Crofts, Y Li, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 18, 2020
Predictive Value of Molecular Subtypes in Premenopausal Women with Hormone Receptor-positive Early Breast Cancer: Results from the ABCSG Trial 5Zsuzsanna Bago-Horvath, Margaretha Rudas, Christian F Singer, et al.
Der Pathologe|February 12, 2021
[Systemic consequences and clinical aspects of SARS-CoV-2 infection]Sigurd F Lax, Kristijan Skok, Peter M Zechner, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|February 8, 2008
CYP1B1 is not a major determinant of the disposition of aromatase inhibitors in epithelial cells of invasive ductal carcinomaMostafizur Rahman, Sigurd F Lax, Carrie H Sutter, et al.
Der Pathologe|February 24, 2021
[Practical aspects of COVID-19 autopsies]Peter Boor, Philip Eichhorn, Arndt Hartmann, et al.
Pageof 10